165 results on '"Henig, Oryan"'
Search Results
2. Relationship among sleep, work features, and SARS-cov-2 vaccine antibody response in hospital workers
3. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility
4. Multidrug-Resistant Gram-Negative Bacilli: Infection Prevention Considerations
5. Lowering the Acquisition of Multi-drug Resistant Organism (MDROs) with Pulsed-xenon (LAMP) Study: a cluster randomized controlled, double-blinded, interventional crossover trial
6. Drivers of adaptive evolution during chronic SARS-CoV-2 infections
7. Lowering the Acquisition of Multidrug-Resistant Organisms (MDROs) With Pulsed-xenon (LAMP) Study: A Cluster-Randomized, Controlled, Double-Blinded, Interventional Crossover Trial.
8. Use of antibiotics and factors associated with treatment failure among 152,245 patients with pneumonia treated in the community — a retrospective cohort study
9. Multidrug-Resistant Gram-Negative Bacilli: Infection Prevention Considerations
10. An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections.
11. An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections
12. Nosocomial transmission of MPOX virus to health care workers –an emerging occupational hazard: A case report and review of the literature
13. Bacterial Pneumonia in Older Adults
14. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility
15. Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review
16. A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae
17. Multidrug-Resistant Gram-Negative Bacilli: Infection Prevention Considerations
18. Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients
19. Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
20. Rethinking the “Pan-Culture”: Clinical Impact of Respiratory Culturing in Patients With Low Pretest Probability of Ventilator-Associated Pneumonia
21. Drivers of adaptive evolution during chronic SARS-CoV-2 infections
22. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel
23. Short-Term Safety of Booster Immunization With BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
24. The Performance of Sepsis-3 Criteria to Predict Mortality among patients with hematologic malignancy and post-transplant who have Suspected Infection
25. Use of antibiotics and factors associated with treatment failure among 152,245 patients with pneumonia treated in the community — a retrospective cohort study
26. An outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections among hospital personnel with high mRNA vaccine uptake
27. Antibiotic Use during the COVID-19 Pandemic in a Tertiary Hospital with an Ongoing Antibiotic Stewardship Program
28. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
29. An outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections among hospital personnel with high mRNA vaccine uptake
30. Deferring Amputation in Diabetic Foot Osteomyelitis: Doing More Harm Than Good?
31. Unraveling a Nosocomial Outbreak of COVID-19: The Role of Whole-Genome Sequence Analysis
32. Gut microbiome features are associated with sepsis onset and outcomes
33. Omitting Fluoroquinolones Antibiotic Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Does Not Increase Gram-Negative Bacteremia Rate or Transplant-Related Mortality
34. Short-Term Safety of Booster Immunization With BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers.
35. 318. Deferring Amputation in Diabetic Foot Osteomyelitis: Doing more Harm than Good?
36. Pathogens isolated in respiratory tract samples of recently hospitalized patients: Implications for primary care physicians
37. The Effect of β-Blockers for Burn Patients on Clinical Outcomes: Systematic Review and Meta-Analysis
38. The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot Infections
39. Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial Pneumonia
40. Performance of Sepsis-3 Criteria to Predict Mortality Among Patients With Hematologic Malignancy and Post-transplant who Have Suspected Infection.
41. Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
42. 2222. Impact of Empiric Aminoglycoside Usage on Outcomes in Bacterial Pneumonia
43. 223. Predicting Mortality Among Immunocompromised Patients Who Present With Bloodstream Infection
44. Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan
45. The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli
46. The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification
47. 1567. Predicting Mortality Among Immunocompromised Patients Who Present with Infection
48. 2075. The Hypothetical Impact of Accelerate Pheno on Time to Appropriate Therapy (TTAT) and Time to Optimal Therapy (TTOT) in an Institution with an Established Antimicrobial Stewardship Program and Rapid Genotypic Organism/Resistance Marker Identification
49. 1467. Clinical Significance of Microbiologic Treatment Failure Following Clinical Cure of Pneumonia
50. Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial Pneumonia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.